Hosted on MSN3mon
Clinical trial suggests new drug candidate for spinocerebellar ataxia may offer certain therapeutic benefitsThe trial assessed treatment efficacy using the Scale for the Assessment and Rating of Ataxia (SARA), a standardized tool for evaluating ataxia severity, especially in cerebellar diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback